For many women, menopause symptoms can be more than uncomfortable — they can be life-disrupting. Hot flashes, night sweats, sleep problems, mood changes, joint pain and vaginal dryness can interfere with daily life, work and relationships. Hormone replacement therapy (HRT) is one of the most effective treatments for these symptoms, yet many women remain hesitant to try it because of fears about cancer.

Those concerns often trace back to a “black box warning” that appeared on hormone therapy products more than 20 years ago. So, what do we know now? Has the science changed? And is hormone therapy safe for most women?

Why did hormone therapy get a black box warning?

The black box warning came from findings published in 2002 from the Women’s Health Initiative (WHI), a large study that looked at hormone therapy in postmenopausal women. The study reported a small increase in breast cancer risk among women who took combined estrogen and progestin therapy.

But according to Nebraska Medicine OB-GYN Marcela Pineda Molina, MD, the warning grouped very different treatments — and very different patients — together.

“The black box warning included not only cancer risk, but also cardiovascular risks like heart attack and stroke — and it applied to all estrogen products, including vaginal estrogen,” Dr. Pineda says. “There was no differentiation, even though vaginal estrogen does not reach systemic levels.”

Over time, menopause experts questioned whether the warning truly reflected current science or clinical practice.

How today’s hormone therapy is different

One of the biggest differences between then and now is who receives hormone therapy. The women in the original WHI study were, on average, more than 10 years past menopause and already had higher rates of heart disease.

“We now recommend starting hormone therapy as close to menopause as possible, ideally within 10 years of menopause,” Dr. Pineda explains. “That population is very different from the women studied 20 years ago.”

Another key difference is the type of hormones used. Earlier studies relied heavily on synthetic hormones. Today, most prescriptions use hormones that are chemically identical to what the body naturally produces.

“We no longer use synthetic forms of progesterone when we can,” Dr. Pineda says. “We use micronized progesterone, which appears to have a lower risk of blood clots and may not carry the same breast cancer risk.”

What does the research say about cancer risk?

The connection between hormone therapy and cancer is more nuanced than many women realize.

In the WHI study, women who took estrogen alone actually had a lower risk of breast cancer compared with women who did not take hormones. The slight increase in breast cancer risk was seen only in women who used estrogen combined with certain synthetic progestins.

“These women were not being compared to the general population,” Dr. Pineda explains. “They were compared to women who already had a lower risk of breast cancer. That’s where some of the confusion came from.”

Women who still have a uterus need progesterone along with estrogen to protect against endometrial (uterine) cancer, which is why combination therapy may be recommended.

Does the type of hormone therapy matter?

Yes. Both the type of hormone and the way it’s delivered can affect risk.

Hormone therapy can be given as a pill, patch, spray, cream or vaginal treatment. Oral estrogen passes through the liver and slightly increases the risk of blood clots. Transdermal options, such as patches or sprays, appear to have a lower clotting risk.

“Vaginal estrogen is localized therapy,” Dr. Pineda says. “It treats symptoms like vaginal dryness and painful intercourse without exposing the entire body to estrogen.”

Who should not take hormone therapy?

Hormone therapy may not be recommended for women with a history of:

• Breast cancer.
• Blood clots in the legs or lungs.
• Stroke or heart attack.

“For the vast majority of women in their late 40s and early 50s, hormone therapy can actually provide more benefit than risk,” Dr. Pineda says.

How long can you safely take hormone therapy?

There is no one-size-fits-all timeline for hormone therapy. Instead, the decision is reviewed regularly.

“Every year, it should be revisited with your physician,” Dr. Pineda says. “If a woman is healthy and hormone therapy is allowing her to function and feel well, continuing it can make sense.”

What if hormones aren’t right for you?

Hormone therapy is not the only option. New non-hormonal medications and treatments are available to help manage hot flashes, mood changes and sleep problems. A health care provider can help determine which option is best for you.

“Exercise, sleep and nutrition also play an important role in how we feel during menopause and can improve our health outcomes during this transition period and the years to come,” adds Dr. Pineda.

The bottom line

Menopause is a natural transition — but that doesn’t mean women have to suffer through it.

“For a long time, we told women, ‘This is just aging,’” Dr. Pineda says. “But menopause symptoms can be life-altering. If you’re struggling, you’re not alone, and help is available.”

Your best bet is to find a board-certified gynecologist who is up to date on the most current research regarding hormone therapy and other treatments for menopausal symptoms. A knowledgeable provider can help you weigh the benefits and risks and decide what’s right for you.